CHINA PHARMA HOLDINGS, INC. Customer's Liability for Acceptances, Net
CHINA PHARMA HOLDINGS, INC. (CPHI) had Customer's Liability for Acceptances, Net of $80.41 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes
us-gaap:CustomersLiabilityForAcceptancesNet · last filed 2023-08-14
- 2023-06-30: Customer's Liability for Acceptances, Net $80.41K.
- 2023-03-31: Customer's Liability for Acceptances, Net $34.77K.
- 2022-12-31: Customer's Liability for Acceptances, Net $13.78K.
- 2022-09-30: Customer's Liability for Acceptances, Net $44.80K.
| Period end | Customer's Liability for Acceptances, Net |
|---|---|
| 2023-06-30 | $80.41K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $34.77K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $13.78K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $44.80K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.76K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $14.15K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $91.36K 10-K · filed 2023-03-30 |
| 2020-12-31 | $53.74K 10-K · filed 2022-03-30 |
| 2020-09-30 | $38.47K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $11.25K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $48.10K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $45.76K 10-K · filed 2021-03-26 |
| 2019-03-31 | $51.42K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $20.58K 10-K · filed 2020-03-30 |
| 2018-06-30 | $19.61K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $25.24K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $39.87K 10-K · filed 2019-03-28 |
| 2017-09-30 | $22.92K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $16.69K 10-Q · filed 2017-08-14 |
| 2012-09-30 | $365.25K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $460.28K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $365.29K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $83.51K 10-Q · filed 2012-11-14 |
| 2011-09-30 | $132.17K 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $237.41K 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $0.00 10-Q/A · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |